Rapid Micro Biosystems Inc Cl A (RPID)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -27,903 | -13,887 | -60,806 | -44,359 | -28,020 |
| Depreciation Amortization | 1,530 | 759 | 2,837 | 1,977 | 1,243 |
| Accounts receivable | 1,913 | -142 | -364 | 346 | 905 |
| Accounts payable and accrued liabilities | -4,064 | -4,141 | 1,484 | -275 | -1,122 |
| Other Working Capital | -1,419 | -4,555 | -5,325 | -8,155 | -7,721 |
| Other Operating Activity | 4,067 | 5,280 | 3,627 | 3,574 | 2,928 |
| Operating Cash Flow | $-25,876 | $-16,686 | $-58,547 | $-46,892 | $-31,787 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -974 | -759 | -6,740 | -5,929 | -4,342 |
| Purchase Of Investment | -26,647 | -17,831 | -179,229 | -155,340 | -117,993 |
| Sale Of Investment | 55,000 | 32,500 | 92,500 | 55,000 | 25,000 |
| Investing Cash Flow | $27,379 | $13,910 | $-93,469 | $-106,269 | $-97,335 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -18 | -9 | -33 | -24 | -16 |
| Common Stock Issued | 131 | 131 | 726 | 630 | 471 |
| Financing Cash Flow | $113 | $122 | $693 | $606 | $455 |
| Beginning Cash Position | 27,348 | 27,348 | 178,671 | 178,671 | 178,671 |
| End Cash Position | 28,964 | 24,694 | 27,348 | 26,116 | 50,004 |
| Net Cash Flow | $1,616 | $-2,654 | $-151,323 | $-152,555 | $-128,667 |
| Free Cash Flow | |||||
| Operating Cash Flow | -25,876 | -16,686 | -58,547 | -46,892 | -31,787 |
| Capital Expenditure | -974 | -759 | -6,740 | -5,929 | -4,342 |
| Free Cash Flow | -26,850 | -17,445 | -65,287 | -52,821 | -36,129 |